TNF Inhibitor Use Doesn't Up Short-Term Cancer Incidence

In rheumatoid arthritis, inflammatory bowel disease, psoriasis, or psoriatic arthritis

MONDAY, Oct. 22 (HealthDay News) -- Treatment of chronic immune-mediated diseases with tumor necrosis factor (TNF) inhibitors does not result in any short-term increase in cancer incidence, compared with other commonly used therapies for these conditions, according to a study published online Oct. 10 in Arthritis & Rheumatism.

Kevin Haynes, Pharm.D., of the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues conducted the Safety Assessment of Biologic Therapy study using data from 29,555 patients with rheumatoid arthritis, 6,357 patients with inflammatory bowel disease, 1,298 patients with psoriasis, and 2,498 patients with psoriatic arthritis. The authors sought to compare the incidence of cancer with the use of TNF inhibitors compared with other disease modifying therapies.

The researchers found that, compared with disease-specific alternatives, TNF inhibitor therapy was not associated with an increase in the incidence of any solid cancer in patients with rheumatoid arthritis, inflammatory bowel disease, psoriasis, or psoriatic arthritis. For patients with rheumatoid arthritis, TNF inhibitor therapy was not associated with an increased incidence of any of the 10 most common cancers and non-melanoma skin cancer, compared with methotrexate failure.

"In conclusion, we did not observe an increased incidence of cancer early in the course of treatment among patients treated with TNF-inhibitors in this large cohort study across multiple patient populations," the authors write "The outcomes of long-term therapy will require further study in these or other cohorts."

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Blunt Chest Trauma
Journal of Trauma Nursing, November/December 2014
Expires: 12/31/2016 CE:2 $21.95


The School Age Child with Congenital Heart Disease
MCN, The American Journal of Maternal/Child Nursing, January/February 2015
Expires: 2/28/2017 CE:2.5 $24.95


Understanding multiple myeloma
Nursing Made Incredibly Easy!, January/February 2015
Expires: 2/28/2017 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles

Comprehensive Care: Looking Beyond the Presenting Problem
Journal of Christian Nursing, January/March 2015
Free access will expire on March 2, 2015.


Pain and Alzheimer dementia: A largely unrecognized problem
Nursing Made Incredibly Easy!, January/February 2015
Free access will expire on February 16, 2015.


Glycemic control in hospitalized patients
Nursing2015 Critical Care, January 2015
Free access will expire on February 16, 2015.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events